Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Vaccines01:30

Cancer Vaccines

237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
4.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

4.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Novel approach for vaccine delivery using mRNA lipid nanoparticles for <i>in vivo</i> production of monoclonal antibodies.

Molecular therapy. Nucleic acids·2026
Same author

The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications.

Viruses·2025
Same author

Methuselah proteins in Drosophila: Structural and evolutionary insights from mathematical genomics.

Biochemical and biophysical research communications·2025
Same author

Improved SARS-CoV-2 vaccine based on intranasally administered replicon RNA.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Immunobiology and immunotherapy of COVID-19.

Progress in molecular biology and translational science·2025
Same author

Molecular genomic insights into melanoma associated proteins PRAME and BAP1.

Journal of biomolecular structure & dynamics·2025

相关实验视频

Updated: May 8, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.3K

基于病毒载体的癌症疫苗

Kenneth Lundstrom1

  • 1PanTherapeutics, Lutry, Switzerland.

Methods in molecular biology (Clifton, N.J.)
|April 23, 2025
PubMed
概括

病毒载体,包括腺病毒和晶状病毒,是癌症有效的疫苗输送系统. 这些病毒载体在癌症疫苗开发的临床前和临床研究中表现有前途.

科学领域:

  • 在瘤学瘤学.
  • 病毒学 病毒学
  • 免疫学 免疫学 免疫学

背景情况:

  • 病毒载体被广泛用作疫苗的输送载体.
  • 两种DNA和RNA病毒都已被设计用于疫苗开发.
  • 已经使用了各种病毒平台,包括腺病毒 (Ad),腺相关病毒 (AAV) 和晶状病毒 (LV).

研究的目的:

  • 描述癌症疫苗开发的模型病毒载体系统.
  • 突出病毒载体在癌症免疫治疗中的应用.
  • 审查病毒载体在预防和治疗癌症疫苗接种策略中的使用.

主要方法:

  • 使用各种病毒载体,如腺病毒,AAV,简单疹病毒,隐形病毒,阿尔法病毒,黄斑病毒,麻疹病毒,狂犬病病毒,纽卡斯尔病病毒,小病毒和皮科纳病毒.
  • 工程病毒载体以表达与瘤相关的抗原和免疫刺激基因.
  • 通过使用型病毒直接治疗效果.

主要成果:

  • 在临床前动物瘤模型中建立了预防和治疗概念验证.
  • 在涉及人类癌症患者的临床试验中证明了治疗疗效.
  • 展示了病毒载体在不同癌症疫苗方法中的多功能性.
关键词:
癌症疫苗 癌症疫苗 癌症疫苗临床评估 临床评估免疫治疗是一种免疫疗法.瘤学病毒 瘤学病毒临床前模型是临床前模型.与瘤相关的抗原.病毒载体 病毒载体

更多相关视频

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.1K
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

13.2K

相关实验视频

Last Updated: May 8, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.3K
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.1K
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

13.2K

结论:

  • 病毒载体是开发创新的癌症疫苗的强大平台.
  • 病毒载体的应用在临床前和临床癌症研究中显著有前途.
  • 基于病毒载体的癌症疫苗的进一步开发是有必要的,以改善患者的治疗结果.